Takeda Pharmaceutical Company Limited (TAK): Market Value

The Takeda Pharmaceutical (TAK) portfolio is shifting toward orphan disease therapies, creating critical treatment methods. However, the risk of patent exclusivity loss and debt obligations following M&A deals are creating financial pressure. The market trend of the share price, which reached 68.38, clearly illustrates these processes. Production stability is maintained through a distributed network of modern plants and research centers across Europe, the US, and Japan.

TAK takeda.com: Market Valuation in the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Takeda Pharma (TAK)

- current price and projected stock value:

Stock Price Takeda|TAK - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Takeda Pharma|TAK - Enterprise Value

- book value of equity indicators:

Net Assets per Single Share Takeda|TAK - Net Asset Value|Market Capitalization to Book Value Ratio takeda.com|TAK - Aggregate Asset Value

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

TAK - Final Profit|Projected Future Earnings Takeda Pharmaceutical|TAK - Company Value to Net Income|Future Price to Earnings Takeda Pharmaceutical Company Limited|TAK - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Takeda Pharma|TAK - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Takeda|TAK - Earnings per share for the last 12 months|Quarterly EPS earnings growth takeda.com|TAK - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Takeda Pharmaceutical

- sales volume and revenue information:

TAK - Company Sales Volume|Projected Sales Volume Takeda|TAK - Price-to-Revenue Multiple|Forward Price-to-Revenue Multiple Takeda Pharma

Summary company analysis:TAK (Takeda)

When selecting defensive assets, priority is given to resilient behemoths, which includes Takeda Pharmaceutical (TAK) due to its leadership in ecological transformation and the transition to renewable energy. The issuer's total market capitalization reflects the aggregate value of all shares, measuring the real scale of the business and its ability to withstand market volatility, allowing investors to objectively assess the company's weight within the sector.

Competitors of Takeda Pharmaceutical (TAK)